Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009338
Filing Date
2018-11-14
Accepted
2018-11-14 16:06:54
Documents
64
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20180930x10q.htm 10-Q 1322739
2 EX-31.1 rsls-20180930ex31101ba3f.htm EX-31.1 13647
3 EX-31.2 rsls-20180930ex31236622d.htm EX-31.2 14867
4 EX-32.1 rsls-20180930ex32134da92.htm EX-32.1 11976
5 EX-32.2 rsls-20180930ex32254743f.htm EX-32.2 12091
  Complete submission text file 0001558370-18-009338.txt   6508852

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20180930.xml EX-101.INS 1437571
7 EX-101.SCH rsls-20180930.xsd EX-101.SCH 48596
8 EX-101.CAL rsls-20180930_cal.xml EX-101.CAL 57983
9 EX-101.DEF rsls-20180930_def.xml EX-101.DEF 205930
10 EX-101.LAB rsls-20180930_lab.xml EX-101.LAB 379884
11 EX-101.PRE rsls-20180930_pre.xml EX-101.PRE 335810
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 181183668
SIC: 3845 Electromedical & Electrotherapeutic Apparatus